Moshe BarSimanTov - Uphealth Independent Director
| UPHDelisted Stock | USD 1.61 0.09 5.29% |
Insider
Moshe BarSimanTov is Independent Director of Uphealth since 2021.
| Age | 43 |
| Tenure | 3 years |
| Phone | 312 618 1322 |
| Web | https://uphealthinc.com |
Uphealth Management Efficiency
Uphealth's management efficiency ratios could be used to measure how well Uphealth manages its routine affairs as well as how well it operates its assets and liabilities.Uphealth has 157.48 M in debt with debt to equity (D/E) ratio of 0.42, which is OK given its current industry classification. Uphealth has a current ratio of 0.83, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Uphealth to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Joanne Fong | ATI Physical Therapy | N/A | |
| Steven Damon | Femasys | 68 | |
| Joseph Jordan | ATI Physical Therapy | 42 | |
| Sharon Vitti | ATI Physical Therapy | 59 | |
| Geoffrey Birkett | Ensysce Biosciences | 61 | |
| Ray Wahl | ATI Physical Therapy | 51 | |
| Greg Steil | ATI Physical Therapy | N/A | |
| Edward Moffly | Lottery, Common Stock | 66 | |
| Brent Rhodes | ATI Physical Therapy | 33 | |
| John Larsen | ATI Physical Therapy | 66 | |
| Augustus Oakes | ATI Physical Therapy | 49 | |
| Jeffrey Millard | Ensysce Biosciences | 48 | |
| Linda Pestano | Ensysce Biosciences | 55 | |
| Sohail Quraeshi | Lottery, Common Stock | 68 | |
| MS MD | Femasys | N/A | |
| MSE MBA | Ensysce Biosciences | 52 | |
| Todd MBA | Femasys | 56 | |
| Edward MD | Femasys | 61 | |
| Dov Elefant | Femasys | 57 | |
Management Performance
| Return On Equity | -0.75 | |||
| Return On Asset | 0.003 |
Uphealth Leadership Team
Elected by the shareholders, the Uphealth's board of directors comprises two types of representatives: Uphealth inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Uphealth. The board's role is to monitor Uphealth's management team and ensure that shareholders' interests are well served. Uphealth's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Uphealth's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Avishay Katz, Co-Chairman of the Board | ||
| Michael Labriola, Ex Technology | ||
| Agnes ReyGiraud, Independent Director | ||
| Ramesh Balakrishnan, Chief Executive Officer | ||
| Darren Derosa, Chief People Officer | ||
| Michael Rolla, Chief Revenue Officer | ||
| Ranjani Ramakrishna, Executive Vice President - Legal, Chief of Staff | ||
| Martin Beck, Chief Financial Officer | ||
| Jerome Ringo, Independent Director | ||
| Jamey Edwards, President | ||
| Nathan Locke, Independent Director | ||
| Kerry Moreno, VP Operations | ||
| Sabahat Azim, Chief Executive Officer - International Operations | ||
| Raluca Dinu, Director | ||
| Jason Luchterhand, VP Operations | ||
| Ranjani LLM, Chief Officer | ||
| Mariya Pylypiv, Chief Strategy Officer, Director | ||
| Jeffery Bray, Chief of Legislative and Regulatory Affairs | ||
| Neil Miotto, Independent Director | ||
| Alfonso Gatmaitan, Chief Operating Officer | ||
| Edna Johnson, Chief Communications and Corporate Marketing Officer | ||
| Azfar Malik, President - Behavioral Health | ||
| MBA JD, Chief Officer | ||
| Inderjote Kathuria, Acting Chief Medical Officer | ||
| MD MBA, CoFounder Director | ||
| Samuel Meckey, CEO Director | ||
| Chirinjeev Kathuria, Co-Chairman of the Board | ||
| Nashina Asaria, Chief Product Marketing Officer | ||
| Moshe BarSimanTov, Independent Director |
Uphealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Uphealth a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.75 | |||
| Return On Asset | 0.003 | |||
| Profit Margin | (0.49) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 152.79 M | |||
| Shares Outstanding | 17.78 M | |||
| Shares Owned By Insiders | 47.01 % | |||
| Shares Owned By Institutions | 28.78 % | |||
| Number Of Shares Shorted | 628.85 K | |||
| Price To Book | 0.07 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Uphealth Stock
If you are still planning to invest in Uphealth check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Uphealth's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |